Company Overview
Shalby Limited, a leading healthcare services provider, has disclosed comprehensive financial and operational results for FY 2025-26 through multiple regulatory filings.
Financial Performance
Standalone Results: Revenue from operations reached ₹8,985.58 million with net profit of ₹1,129.09 million. Property, plant and equipment stood at ₹5,948.41 million while total assets amounted to ₹15,948.96 million.
Consolidated Results: The group reported revenue of ₹11,414.29 million with net profit attributable to equity shareholders of ₹346.84 million. Total assets were ₹15,125.07 million, with significant investments in subsidiaries totaling ₹5,646.81 million. The medical-technology business turned profitable with operating profit of ₹7 crore.
Tax Transition: The company adopted the new tax regime under Section 115BAA, resulting in a one-time tax impact of ₹340.16 million and MAT credit write-off of ₹42.36 million.
Corporate Governance & AGM
Shalby announced its 22nd Annual General Meeting scheduled for September 10, 2026, to be held virtually. Key agenda items include adoption of FY26 financial statements and appointment of Mr. Shanay Vikram Shah as Whole-Time Director for a five-year term with remuneration up to ₹1.50 crore annually. The cut-off date for e-voting is September 3, 2026.
Business Responsibility & Sustainability
The BRSR report detailed environmental initiatives including thermal insulation for HVAC efficiency, infrared water tap controllers, and rainwater harvesting. Employee coverage statistics showed 2,217 permanent employees with 96% accident insurance coverage. Training programs reached 2,838 employees with 89.92% receiving health and safety training.
Audit & Compliance
Auditors issued unqualified opinions on both standalone and consolidated financial statements, highlighting key audit matters including material uncertain legal & tax positions (₹493.48 million), allowance for expected credit losses, impairment assessment of investments, and revenue recognition under Ind AS 115.
Subsidiaries & Investments
The group comprises 14 subsidiaries including Shalby Advanced Technologies India Private Limited, Shalby Global Technologies Pte. Ltd., and Shalby Kenya Limited. An impairment provision of ₹6.96 million was recognized for investment in Yogeshwar Healthcare Limited.
Capital Structure & ESOP
The company maintains authorized share capital of ₹1,177.50 million with 107,519,005 equity shares issued and fully paid-up. Two ESOP schemes have 116,000 and 1,091,000 options outstanding respectively.
Contingent Liabilities & Commitments
Significant contingent liabilities include income tax demands (₹55.40 million), VAT demands (₹84.82 million), and corporate guarantees to banks on behalf of subsidiaries (₹4,936.01 million). Capital commitments stood at ₹328.95 million.